Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.
- DOI
- 10.1002/edm2.70313
- Published
- 2026-09-01
- Container
- Endocrinol Diabetes Metab
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/edm2.70313,
title = {Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.},
author = {Hageen AW and Gadelmawla AF and Saleh AO and Bahnasy S and Eladawi S and Abdelaziz M and Iyad K and Kandil AH and Zinhom K and Mohamed MR and Abdulhay H and Turkman M and Abdelazeem B and Fonarow GC.},
year = {2026},
journal = {Endocrinol Diabetes Metab},
doi = {10.1002/edm2.70313},
url = {https://doi.org/10.1002/edm2.70313}
}RIS
TY - JOUR TI - Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials. AU - Hageen AW AU - Gadelmawla AF AU - Saleh AO AU - Bahnasy S AU - Eladawi S AU - Abdelaziz M AU - Iyad K AU - Kandil AH AU - Zinhom K AU - Mohamed MR AU - Abdulhay H AU - Turkman M AU - Abdelazeem B AU - Fonarow GC. PY - 2026 JO - Endocrinol Diabetes Metab DO - 10.1002/edm2.70313 UR - https://doi.org/10.1002/edm2.70313 ER -
APA
AW, H., AF, G., AO, S., S, B., S, E., M, A., K, I., AH, K., K, Z., MR, M., H, A., M, T., B, A., & GC., F. (2026). Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.. Endocrinol Diabetes Metab. https://doi.org/10.1002/edm2.70313
Source records
- europe-pmc · retrieved 2026-09-27T03:33:51.237Z
- doaj · retrieved 2026-09-27T03:33:51.269Z